In this article, a single-label separation-free fluorescence technique is presented as a potential screening method for cell-based receptor antagonists and agonists.The time-resolved fluorescence technique, quenching resonance energy transfer (QRET), relies on a single-labeled binding partner in combination with a soluble quencher. The quencher efficiently suppresses the luminescence of the unbound labeled ligand, whereas the luminescence of the bound fraction is not affected. This approach allows the development of cell-based screening assays in a simple and cost-effective manner. The authors have applied the technique to the screening of β 2 -adrenoreceptor (β 2 AR) antagonists and agonists in intact human embryonic kidney HEK293 i cells overexpressing human β 2 -adrenergic receptors. Two antagonists (propranolol, alprenolol) and 2 agonists (metaproterenol, terbutaline) for β 2 AR were investigated in a displacement assay using europium(III)-labeled pindolol ligand. The assay Z′ values ranged from 0.68 to 0.78, the coefficient of variation was less than 10%, and the K i values were 19 nM for propranolol and alprenolol and 14 and 5.9 µM for metaproterenol and terbutaline, respectively. The QRET technique with β 2 AR was also applied to LOPAC compound library screening, yielding nearly error-free recognition of known binders. This simple and cost-effective technique can be readily adapted to laboratory and industrial-scale screening. (Journal of Biomolecular Screening 2009:936-943) 
INTRODUCTION
W ithin the past 2 decades, high-throughput screening (HTS) technologies have been developed for different bioanalytical applications such as drug development, clinical diagnostics, proteomics, and genomics. Nowadays, HTS technologies are an integral part of drug discovery processes. However, there is a need for more rapid, simple, efficient, and cost-effective screening techniques in pharmaceutical screening of large compounds libraries. 1, 2 Technological advancements in robotics and cell-based assays have had a significant impact on HTS. Particularly, end users welcome such improvements because large screening campaigns can be successfully performed with low cost and produce information with better relevance than obtained by simple biochemical assays. Cellbased assays have gained popularity with end users because the assays can be used to test compounds directly on living cells, generating quality leads and accelerating lead validation processes. Today, such screening approaches are frequently used to screen compound libraries.
We have developed a novel receptor-ligand assay technique for library screening purposes. The quenching resonance energy transfer (QRET) technique is based on a fluorescence quenching mechanism ( Fig. 1) and offers a nonradioactive alternative to the traditional radioligand binding assays. 3, 4 A soluble quencher molecule is applied in the assay buffer to preferentially quench the fluorescence of the unbound labeled ligand in solution. The bound labeled ligand is protected against the quenching effect upon binding (Fig. 1) . The detection relies on time-resolved luminescence, which is by far more sensitive than conventional fluorescence. 5 The unique fluorescence properties of lanthanide chemistry have led to the development of successful diagnostic and screening methods. Methods using time-resolved fluorescence resonance energy transfer techniques have been developed and applied to HTS. 6, 7 The QRET technique is a simplified homogeneous assay concept with fewer manipulation steps compared with existing timeresolved fluorescence resonance energy transfer (TR-FRET) methods. This is due to the single-label approach as compared with dual labeling of the TR-FRET methods. In the QRET technique, a binding ligand is labeled with lanthanide (Ln) (III) chelate. In a screening assay, a receptor binding site is competed with the labeled ligand and library binding candidates.
We have applied the technique to a cell-based receptorligand screening study of β 2 -adrenoreceptor (β 2 AR). β 2 AR belongs to the superfamily of G-protein-coupled receptors (GPCRs) representing the largest family of cell surface receptors and one of the most important drug targets for the pharmaceutical industry. [8] [9] [10] GPCRs are involved in a wide range of disorders and disease states including ulcer, psychosis, anxiety, Parkinson disease, Alzheimer disease, and hypertension. [11] [12] [13] [14] It is reported that nearly 50% of current drug targets belong to GPCRs. In addition, about 20% of the top 50 best-selling drugs target the GPCR family. 15, 16 In this study, 2 antagonists (propranolol, alprenolol) and 2 agonists (metaproterenol, terbutaline) of β 2 AR were studied to characterize the assay system. The studies were performed on intact HEK293 cells overexpressing β 2 AR. In addition, the LOPAC compound library consisting of 1280 well-characterized, pharmaceutically diverse compounds with known drug activity was tested in our model system.
MATERIALS AND METHODS

Materials
Dulbecco's Modified Eagle's Medium high glucose (DMEM high glucose), fetal bovine serum (FBS), penicillin/streptomycin solution, and trypsin/EDTA solution were purchased from Euroclone (West York, UK). The antibiotics blasticidin and hygromycin were purchased from InvivoGen (San Diego, CA). Phosphate-buffered saline (1×PBS) for cell culture was obtained from Lonza (Basel, Switzerland). The β 2 AR was stably expressed in human embryonic kidney 293 cells (HEK293) by transfection with the receptor cDNAs cloned into the expression vector pFT-SMMF. The stably expressing cell line was a generous gift from Dr. Ulla Petäjä-Repo (University of Oulu, Finland). The compounds propranolol, alprenolol, metaproterenol, terbutaline, bovine serum albumin (BSA), L-glutamine, leucoberbelin blue I, and LOPAC library were purchased from Sigma (St. Louis, MO). The Eu-C12-pindolol ligand was synthesized at the Laboratory of Biophysics, University of Turku, Finland. 17 For HTS experiments, 384-well assay plates were purchased from Greiner Bio-One (Frickenhausen, Germany).
Instrumentation
In assay development experiments, the luminescence signal of Eu-C12-pindolol ligand was counted with the Victor 2 High signal Low signal fluorescent plate reader (Wallac Oy, PerkinElmer Life and Analytical Sciences, Turku, Finland). The delay and integration times were 400 µs, and the excitation and emission wavelengths were 340 and 615 nm, respectively. The U-2900 spectrophotometer was from Hitachi (Tokyo, Japan). HTS mode detection was performed with EnVision 2101 multilabel plate reader (Wallac Oy), with settings corresponding to assay development mode. The library compounds were transferred on assay plates with Microlab Star automated liquid-handling workstation (Hamilton Robotics, Reno, NV) fitted with 100-nl 96-channel pintool (V&P Scientific Inc., San Diego, CA). HTS mode cell, ligand, and quencher dispensation was carried out using a Multidrop Combi dispenser (Thermo Fisher Scientific, Waltham, MA).
Cell culture
Stably expressed human embryonic kidney 293 cells (HEK293 i ) 17 were grown at an atmosphere of 95% air and 5% CO 2 at 37 °C in growth medium (DMEM high glucose, 10% FBS, 1% penicillin/streptomycin solution, 2 mM L-glutamine, 1 µg ml -1 blasticidin, and 100 µg ml -1 hygromycin). Cells were grown to 80% to 90% confluence in 100-mm culture plates, washed with 1×PBS, and passaged with the use of trypsin/ EDTA solution. The cells were collected and kept at -70 °C before use. A 50% to 60% confluent 100-mm plate was induced by adding 0.5 µg ml -1 tetracycline to the growth medium 1 day before collecting. After harvesting, cells were washed twice with 1×PBS, scraped from the plate, collected to a vial, and centrifuged at 800 × g at 4 °C. Then, supernatant was discarded and cells were resuspended in 1×PBS and counted. Cells were centrifuged again, and pellets were immediately frozen in liquid nitrogen.
Homogeneous binding assay
Binding assays were performed on transfected intact HEK293 cells. On the day of the assay, cells were thawed, resuspended in 1×PBS, and counted with the hemocytometer. The cell concentration was adjusted to 500,000 cells in 50 µl. The reaction compounds were added to 384-well plates as follows: 1.5 µl of agonist or antagonist in DMSO (final concentration 2.5% in 60 µl), 500,000 cells in 50 µl, and 10 µl of 18 nmol l -1 Eu-C12-pindolol ligand prepared in 1×PBS containing 0.1% BSA. The reaction solution was incubated on the plate for 30 min at room temperature in the dark with low shaking. After incubation, 980 µmol l -1 quencher solution, leucoberbelin blue I, was added in a volume of 10 µl, yielding a total volume of 70 µl. The 384-well plates were mixed for 1 min at low shaking, and the time-gated luminescence signal was measured using the Victor 2 fluorescent plate reader. The HTS mode LOPAC library study was carried out with the same assay protocol as described above but adapted to the HTS instrumentation.
The library compounds were printed on 384-well plates in 100 nl from 0.1 mmol l -1 and 1 mmol l -1 stock libraries in DMSO solution using pintool technology and an automated liquid-handling workstation. Ready-to-use assay plates were stored at -20 °C prior to assaying. Cells, Eu-C12-pindolol, and leucoberbelin blue I were dispensed using the Multidrop Combi dispenser, resulting in 0.17 and 1.7 µmol l -1 final compound concentrations in the total assay volume of 60 µl. The EnVision 2101 multilabel reader was used for HTS mode measurement. Raw data were normalized using the B-score method 18 implemented in R, a software environment for statistical computing. 19 A threshold of 2 for signal-to-background ratio was used as the hit criterion. Signal-to-background is defined as µ max/ µ min , coefficient of variation (CV) is determined as (σ/µ) × 100, K i is defined as IC 50 /(1 + C/K d ), and Z′ is defined as 1 -[(3σ max + 3σ min )/|µ max + µ min )|], where µ is the mean of the signal, σ is the standard deviation, IC 50 is half maximal inhibitory concentration, C is the free-labeled ligand concentration, and K d is the dissociation constant.
RESULTS AND DISCUSSION
The principle of the QRET technique
A simple homogeneous QRET concept for cell-based HTS was developed using a single-label approach and quenching of time-resolved luminescence ( Fig. 1) . 20 Intact cells were incubated with agonist or antagonist, and subsequently, lanthanide(III) chelate labeled ligand was allowed to react with the cell receptors. When no agonist or antagonist was added, the receptor binding sites were occupied by the labeled ligand. By adding an agonist or antagonist, the labeled ligand was displaced and remained in solution, and the time-resolved luminescence signal of Ln(III) chelate was quenched by the soluble quencher molecules. The bound fraction of the labeled ligand was protected from quenching upon binding to receptor, apparently because of sterical constraints preventing proximity of the Ln(III) chelate and the quencher molecule. The quenching mechanism was not further characterized as quenching was efficient, allowing no reasonable fluorescence signal for detection.
We applied the QRET technique to a receptor-ligand binding assay of β 2 AR. Stably transfected HEK293 i cells were induced, harvested, frozen, and thawed before being subjected to the assay. An agonist or antagonist ligand, Eu(III) labeled ligand, and soluble leucoberbelin blue I quencher at micromolar concentration were added to a 384-microtiter well. Figure 2 shows the fluorescence and absorption spectra for Eu-C12pindolol and the quencher, respectively. Time-gated Eu(III) luminescence signal was detected after a 30-min incubation. At low ligand concentration, high signal level was detected as the label of Eu(III) pindolol was protected when bound to the β 2 AR. At high ligand concentration, the labeled ligand was free in solution, and the protection of the label was lost. The signal-to-background ratio of the assays was defined as the ratio between the sample not containing ligands and the sample containing agonist or antagonist. At high ligand concentration, inefficient quenching of the labeled ligand contributed to the fluorescence signal level, reducing the signal-to-background ratio. This could be compensated for by increasing the concentration of the quencher. However, this led to reduced fluorescence signal at the zero ligand concentration when the labeled ligand was bound to the receptor. Therefore, there is an optimal quencher concentration window for optimal assay performance.
The influence of the number of cells on Eu-C12-pindolol ligand binding to β 2 AR
Typically, receptor-ligand interactions are investigated with fractions of cell membrane in drug screening studies. [21] [22] [23] This study was based on a homogeneous and quantitative assaying of receptor-ligand interaction using whole intact cells. The cells were frozen after culturing and subsequent harvesting and thawed for assaying. Freezing of cells made it possible to collect a large number of cells for library screening. The optimal number of cells in an assay was estimated by testing 11 different cell concentrations (Fig. 3) .
The luminescence signal level obviously depends on the number of receptors per cell and the number of cells. High signal level was obtained, as expected, at a high cell count, as Eu-C12-pindolol was interacting with the receptors and less unbound soluble Eu-C12-pindolol remained in solution. The number of receptors per cell has been previously determined in a saturation ligand-binding assay by washing Eu-C12pindolol-saturated induced HEK293 cells and subsequently releasing Eu(III) ion to fluorescence enhancement solutions for fluorescence measurement. 17 We found 240,000 receptors per cell and calculated a K d value of 37 nM for the Eu-labeled ligand. A K d value of 1.3 nM was obtained in a radioligand membrane-based saturation assay with [ 3 H]dihydroalprenolol as a radioligand with the same cell line. A washing step was carried out in the saturation experiment because of the limits of the QRET detection principle: The quenching mechanism became inefficient at high labeled-ligand concentrations, and no apparent saturation was reached at an increasing amount of the labeled ligand. In the QRET assay, fluorescence signal was saturated when 2 × 10 6 cells were applied, indicating that nearly all Eu-C12pindolol was bound (Fig. 2) . In the subsequent experiments, 5 × 10 5 cells per assay were chosen, as a signal-to-background ratio of more than 8 (propranolol concentration 0 and 9 µM) was reached. The reduced number of cells in the assays provides more cost-effective assays yet offers adequate performance. At lower cell concentrations, the signal-to-background ratio became less favorable for the assay performance.
The influence of DMSO concentration on Eu-C12-pindolol ligand binding to β 2 AR
Most small molecules in screening libraries are soluble in DMSO. However, cells tolerate DMSO differently, leading to variations is screening studies and influencing library compound recognition. In addition, current robotics and storage conditions favor the use of low-volatile organic solvents, which improve the storage lifetime of prepared library compounds on microplates. We tested 10 different DMSO concentrations for assay functionality ranging from 0% to 10% using 5 × 10 5 cells in an assay. The effect of DMSO was measured in the presence of antagonist propranolol at 0-and 9-µM concentrations. The results are shown in Figure 4 , in which a signal-to-background 
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ratio was calculated to each DMSO concentration. DMSO concentration up to 10% could be applied in the assay, indicating that the QRET method is rather robust. At concentrations higher than 5%, the signal-to-background ratio of less than 4 was achieved. Apparently, cells disrupted at these DMSO concentrations, which could lead to less efficient functional cell assays. However, the QRET ligand binding assay tolerated well relatively high DMSO concentrations. We chose to use a DMSO concentration 2.5% or less in screening studies with a signal-to-background ratio of more than 5.
Homogenenous β 2 AR receptor ligand binding study
We measured β 2 AR ligands at different concentrations using intact cells and the homogeneous single-label QRET technique. Among the known β 2 AR agonists and antagonists, we chose 4 well-known ligands-antagonists propranolol and alprenolol and agonists metaproterenol and terbutaline-for dose-response curve studies. Assays were carried out on a 384-well plate format under optimized conditions in a 30-min assay (Fig. 5) . The kinetic studies of the reaction after addition of the quencher showed a stable fluorescence signal as monitored at 1 min, 30 min, 24 h, and 72 h. The signal change within the different time points was no more than 11% in 2 independent measurement sets when 0-and 9-µM propranolol concentrations were applied (data not shown). The assay CV in the dose-response study was 6% to 9%, and the K i values were 19 nM for both alprenolol and propranolol and 14 and 5.9 µM for metaproterenol and terbutaline, respectively. The signal-to-background ratios for metaproterenol, terbutaline, alprenolol, and propranolol in the ligand displacement assays were 7.0, 10.4, 7.9, and 10.0, and the Z′ values were 0.68, 0.69, 0.76, and 0.78, respectively. We have previously measured the K i value for propranolol in a radioligand washing assay using [ 3 H]dihydroalprenolol ( Fig. 5) . 17 The K i value of 11 nM was in accordance to the results obtained with the QRET technique.
Compound library screening using the QRET method
The LOPAC library consisting of 1280 well-characterized compounds was used to validate the cell-based QRET method for β 2 -adrenergic receptor antagonists and agonists screening. The assay was adapted from the initial manual protocol to an automated robotic test system. We printed the LOPAC library to 384-well plates in DMSO with 2 different concentrations of screening compounds: 0.17 and 1.7 µM. A primary screening using the entire library was conducted using the compound concentration of 1.7 µM without replicates on 4 plates (Fig. 6) . Data were normalized applying the B-score method. We obtained 31 hits including 15 predicted hits when using a threshold value of 2 for signal-to-background ratio. The hit rate to the nonreplicate screen was 2.4%. Confirmation of specificity was carried out in the manual mode for the 31 hits. The hits were studied on additional prepared plates containing the entire compound library at 1.7 and 0.17 µM concentrations by selecting 31 individual wells for the study without replicates. First, the screening was performed on the 1.7-µM plate and, subsequently, on the 0.17-µM plate. The 2 additional screens reduced binding to the hβ 2 AR on intact cells by propranolol (○). The K i value for propranolol in the radioligand displacement assay was 11 nM, and the K i values for metaproterenol, terbutaline, alprenolol, and propranolol in the QRET assay were 14, 5.9, 19, and 19 nM, respectively. the number of hits to 16 ( Table 1) including the 15 predicted, known high-β 2 AR binders during the triple single screens corresponding to known high-binding β 2 AR agonists or antagonists. This suggests that the QRET method has a high success rate and specificity as a screening tool. We expected to measure solely agonist or antagonist with high affinity toward β 2 AR because a compound library concentration of 0.17 µM was applied. However, β 2 AR agonist formoterol was detected as a hit, although the K i value of formoterol did not warrant its detection ( Table 1 ). The detection of formoterol resulted in a false-positive rate of 1/1280 (0.08%).
Comparison with other techniques
Fluorescence polarization assay as a single-label method is widely applied in HTS campaigns: It relies on the rotational diffusion of freely moving labeled ligand, which can be subject to different disturbances. Small-molecule compounds can also be fluorescent and can potentially cause interference to the polarization assay, resulting in false-negative or false-positive data when conventional rapidly decaying fluorescent dyes are applied in detection. Furthermore, the sensitivity of fast decaying fluorescent assays is limited. Fluorescence lifetime analysis is also a single-label approach and has been applied to screening studies. 29, 30 Fluorescence lifetime analysis is relatively independent of the assay setup and instrumental factors. It is also independent of the fluorophore concentration which must be carefully adjusted in fluorescence intensity measurements such as fluorescence polarization. However, the applicability of the fluorescence lifetime analysis in bioassays is limited because of unpredictable effects of library and assay components to fluorescence lifetime signal. Time gating the fluorescence detection allows reduction of such effects because no rapidly decaying fluorescence is detected and the system is inherently more sensitive. 5 TR-FRET assays are also extensively used as screening methods. 6, 7 TR-FRET assays are carried out in the presence of rapidly decaying acceptor dyes, and therefore, fluorescent ligand molecules may be a potential source of interferences. However, less effort has been addressed to the use of TR-FRET in cellbased receptor-ligand binding assays, although such assay developments can be found in the literature. 31 The QRET technique is based on the time-gated detection, allowing the monitoring of luminescence at longer decay times compared with luminescence (shorter decay time) sensitized through acceptor dyes. This provides fewer constraints to instrumentation because commercially available cost-effective light sources produce a significant background signal at shorter decay times desirably used for TR-FRET-based acceptor luminescence detection. The generation of QRET luminescence signal requires no rapidly decaying dyes, and unbound ligands labeled with lanthanide chelate are quenched in solution by a chosen quencher molecule or even by components in a buffer solution. Therefore, the interferences of these buffer components including screening compounds to the detection are low. In addition, the method has advantages over radioligand assays as no radioactive compounds having a limited shelf lifetime and complicated use and disposal procedures are applied.
CONCLUSIONS
The use of technologically advanced methods and cell-based assays in screening campaigns has had a significant impact on HTS. Obtaining more value-added information and lower cost compared with existing technologies is a driving force (S)-(-)-Propafenone hydrochloride 47 26 15 S(-)-Pindolol 4.8 25 16 S(-)-Timolol maleate 0.5 28 a. The K i values given are based on the indicated references.
FIG. 6. Primary LOPAC library screening study using 1.7 µM compound concentration. Sixteen hits after triple single screens are indicated (see Table 1 ). 
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Library compounds of this trend. Along this line, our scope was to simplify current TR-FRET-based assay concepts using a single-label strategy. Eliminating the need for dual labeling potentially reduces overall cost and increases the efficiency of screening because no additional binding components with covalent coupling of acceptor dyes are required and fewer compromises in assay design must be performed. In addition, the developed method allows the use of time-resolved luminescence-based detection in an intact cell-based assay system for receptor-ligand studies. The study shows the usefulness of the QRET technique in screening studies. β 2 AR was chosen as a model system, and successful receptor-ligand displacement assay and library screening studies were performed. Obviously, the developed method can be applied to other receptor-ligand interaction studies on intact cells. In our laboratory, the current investigation also suggests that the method is potentially applicable to immunoassays and non-cell-based receptor studies as long as the labeled ligand can be protected from quenching by receptor binding (data not shown).
